Colonoscopy in HIV Patients, Part II: Problem (Mostly) Solved

April 24th, 2009

Colonoscopy in HIV Patients, Part II: Problem (Mostly) Solved

Both here and on the AIDS Clinical Care site, we posted a case of a 50-year-old HIV+ man in need of a screening colonoscopy. What sedation could he receive while on tenofovir/FTC and ritonavir-boosted atazanavir? Specifically, would midazolam and fentanyl (“contraindicated” in the ritonavir package insert) be ok?

(Same issue for efavirenz, by the way.)

We solicited responses from two PharmD’s and a gastroenterologist, and also received a bunch of comments.

The comments vary in specifics, but the most common is similar to this one, echoing what Brian Fennerty wrote:

These sedative drugs are always titrated to effect for individual patients. We are aware that responses are variable and I think it completely unnecessary to alter an HIV patient’s drug regimen to allow them to receive the discussed drugs. In my experience, I have never noticed a marked exaggeration in clinical effects in this scenario anyway. Bolus doses should be reduced and given with more caution, in the same manner that we approach any patient with altered metabolism, such as the elderly, or those known to have hepato-renal failure.

Or said another way, by a clinician receiving ART himself:

As someone who happens to be on efavirenz I received midazolam and fentanyl for a colonoscopy without incident at age 57 two years ago. The dosage used of both medications was comparable with that I have given patients many times for short relatively pain-free procedures before I retired from the practice of anesthesiology Dr. Fennerty’s approach is the one my gastroenterologist used and is one that I endorse. Giving sedation is all about titration according to individual response and circumstances. The additional caveat I have to make is that since the patient could have a prolonged response is to make sure that the recovery personnel are aware of that fact and are prepared to keep the patient under observation for as long as necessary. This might mean scheduling the case earlier in the day so there is no time pressure to discharge the patient.

We may never have complete consensus on this issue, but ultimately this makes the most sense — use the usual drugs, but be aware that there might be a clinically-relevant interaction in some patients.

Categories: Antiretroviral Rounds, HIV, Infectious Diseases, Patient Care
Tags: aids clinical care, anesthesiology, caveat, clinician, drug regimen, efavirenz, gastroenterologist, HIV, hiv patient, metabolism, midazolam, package, PharmD, ritonavir, screening colonoscopy, sedation, sedative drugs, titration

You can follow any responses to this entry through the RSS 2.0 feed. Both comments and pings are currently closed.

Global Cholera-Control Efforts — Progress and Remaining Challenges June 6, 2026

If the current cholera pandemic, which began in 1961, is ever to end, the world will need better cholera vaccines that are effective in young children and global access to safe water and adequate sanitation.

Childhood Vaccine Hesitancy June 4, 2026

Vaccine hesitancy is often driven by safety concerns. Clinician recommendations, presumptive communication, and empathy improve uptake; maintaining trust supports future acceptance and community protection.

War and Famine June 4, 2026

The prevalence of wasting among children in Gaza tracks with Israeli blockades on aid, but war may lead to famine even without such policies. How should starvation be prevented and treated in wartime?

The Unusual Suspects June 4, 2026

A 53-year-old man with Crohn’s disease and psoriasis presented with a 2-day history of headache, slurred speech, nausea, and vomiting. During the previous 2 weeks, he had had yellowing of the skin and eyes and dark urine.

Sudan Virus Disease in Uganda, 2025 June 3, 2026

In January 2025, an outbreak of disease caused by Sudan virus, an ebolavirus, was identified in Uganda. Characteristics of this outbreak are described.

HIV and ID Observations

An ongoing dialogue on HIV/AIDS, infectious diseases,
all matters medical, and some not so medical.

April 24th, 2009